Navigation Links
Study begins to reveal clues to the cause and progression of sepsis
Date:8/13/2007

aid Derek C. Angus, M.D., M.P.H., professor and vice chair of research, department of critical care medicine, University of Pittsburgh School of Medicine. In response, the National Institutes of Health embarked on the Framingham Heart Study, the results of which have influenced everything we know about the prevention and treatment of cardiovascular disease. With our study, were hoping to do the same for sepsis, providing a greater understanding of the disease on which future treatment and prevention strategies can be based.

For this analysis, researchers evaluated data from 1,886 of the study participants who were hospitalized with community-acquired pneumonia (CAP), the leading cause of severe sepsis. More than 30 percent of the subjects developed severe sepsis, of whom 26 percent died.

To determine the inflammatory response in the participants with CAP, the researchers measured cytokine levels daily for the first week of hospitalization and then weekly thereafter. They found that 82 percent of the participants with CAP had elevated cytokine levels. Levels were highest when the subject presented at the emergency room, tapered down over the first few days, but remained elevated throughout the first week of hospitalization even after the clinical signs of infection had subsided. Levels were highest in those with fatal severe sepsis, lowest in those with CAP but no sepsis.

Our data show that much of what we previously thought about the role the inflammatory response plays in sepsis was wrong or incomplete. We had thought the inflammatory response to infection was relatively short-lived, just a few days, and that it was similar in patients with similar clinical signs. Instead, we found that the inflammatory response was extremely variable across patientsmore than 50-fold differences were seen in some markers. Additionally, we found that the inflammatory response extends past the outward symptoms, far longer than previous data would suggest
'/>"/>

Contact: Jocelyn Uhl Duffy
UhlJH@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Bioartificial kidney under study at MCG
2. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
3. W.M. Keck Foundation funds study of friendly microbes
4. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
5. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
6. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
7. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
8. Study Links Ebola Outbreaks To Animal Carcasses
9. Genome-wide mouse study yields link to human leukemia
10. Breakthrough Microarray-based Technology for the Study of Cancer
11. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...ALBUQUERQUE, N.M. Most scientists believe that st...that signal each other to emit toxins. The signali...acteria must be present to start the process. , ... that the very first stage of staph infection, whe...rm, occurs in a single cell and that this individu...
(Date:12/3/2009)...rest dwellers must be included in the design of th...void a humanitarian crisis, according to a scienti...in Nature , Dr Simon Lewis argues that at least 5...openhagen, known as REDD (Reducing Emissions from ...forest dwellers directly, and their property right...
(Date:12/3/2009)...e 30-year record low in Antarctic snowmelt that oc...y due to concurrent strong positive phases for two...illation) and SAM (Southern Hemisphere Annular Mod...essor of Earth & Atmospheric Sciences at The City ...is also on the doctoral faculty at the CUNY Gradua...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2CCNY professor foresees rising Antarctic snowmelt 2Newly Launched Free Choice Foundation Attempts Rescue of Japan 26apos 3Bs Private Heath Care Network 50481 1Newly Launched Free Choice Foundation Attempts Rescue of Japan 26apos 3Bs Private Heath Care Network 50481 2Newly Launched Free Choice Foundation Attempts Rescue of Japan 26apos 3Bs Private Heath Care Network 50481 3Gerresheimer Sells Technical Plastics Business 12861 1Gerresheimer Sells Technical Plastics Business 12861 2Triggering muscle development a therapeutic cure for muscle wastage 3F 9077 1
... has successfully protected mice and ferrets again...g to the investigator who led the study at St. Jud...veloped by Vical Incorporated in San Diego, Califo...ious studies that showed protection against multip...accine would protect humans against multiple varia...
...e water cycle and havens for wildlife, but they ar... in collaboration with the Ramsar Convention Secre...tellite imagery to provide detailed wide-area view... conservation efforts. , Because the success of we...dual wetland managers, the GlobWetland products an...
...experimental targeted therapy with a common anti-i... with advanced lung cancer, researchers at UCLA,s ...geted therapy Tarceva with the anti-inflammatory d...er patients by about three-fold, said Dr. Karen Re...gy and lead author of the study. The research appe...
Other Biology News:St. Jude test of bird flu vaccine proves successful 2African wetland managers armed with new technology 2Combination therapy shows promising results in patients with advanced lung cancer 2Combination therapy shows promising results in patients with advanced lung cancer 3
(Date:12/4/2009)...if., Dec. 4 BlueFire Eth...pany focused on changing the world,s transportatio...from non-food cellulosic wastes, has been ranked n...Hottest Companies in Bioenergy;" the company,s sec... voters rank BlueFire Ethanol among the top 20 bio...
(Date:12/3/2009)..., Dec. 3 Shire plc (LSE:...armaceutical company, today announced a voluntary ...l of one lot of the Attention-Deficit/Hyperactivit... taking this action because some Daytrana patches ...lease liner removal specification, and as a result...
(Date:12/2/2009)...d., Dec. 2 Martek Biosci... that it intends to release the results of its fou...009, at approximately 4:00 p.m. Eastern Time (ET)....ll conduct a conference call to discuss these resu...sten to the call live via webcast by visiting Mart...
(Date:12/2/2009)...c. 2 Nearly 600 medical...nd funders today convened to explore novel develop...at the inaugural Partnering for Cures meeting. ...f the Milken Institute, convened Partnering for C...eded to turn a scientific discovery into an access...
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
...QC, Sept. 15 /PRNewswire-FirstCall/ - Neptune Tech...NEPT - TSX.V.NTB) reported today,that its distribu...ed,Schiff(R) MegaRed(TM) containing Neptune Krill ...gest retail pharmacy chain in the United States,wi...gaRed(TM) has been made,available at all locations...
...GO, Sept. 15 BioMed Realty Trust, Inc.,(NYSE: BM...s declared a,third quarter 2008 dividend of $0.335...lent to an annualized dividend of $1.34 per common...directors has declared a,dividend of $0.46094 per ...Redeemable Preferred Stock for the period from Jul...
...perts to Answer Questions about Attention Deficit ...(ADHD), NEW YORK, Sept. 12 The 10th annual ,ADHD...sday, September 17, 2008, from 8 a.m.,to midnight ... with,Attention Deficit Hyperactivity Disorder (AD...nity to ask questions and learn more about ADHD fr...
Other Biology Technology:Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM) 2Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM) 3BioMed Realty Trust Declares Third Quarter 2008 Common Stock and Preferred Stock Dividends 2Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 2Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 3Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 4Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 5Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 6
Rhodamine-B-isothiocyanate from Research Organics, Inc.
Anti-Human sIL-2R / CD25 ELI-PAIR Kit Antibody, Unconjugated from Cell Sciences
Mouse Anti-Human STX18 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-Human Lipid Phosphate Phosphohydrolase 2 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Biology Products: